syndrome: An evidence-based review. Journal of Clinical Oncology, 26 (16), 2767-2778. doi:10.1200/JCO.2007.15.0177 Corbacioglu, S., Carreras, E., Mohty, M., Pagliuca, A., Boelens, J. J., Damaj, G., . . . Richardson, P. (2016). Defibrotide for the treatment of hepatic veno-occlusive disease: Final results from the International Compassionate-Use Program. Biology of Blood and Marrow Transplantation, 22 (10), 1874–1882. doi:10.1016/j.bbmt.2016.07.001 Co-Reyes, E., Li, R., Huh, W. e Chandra, J. (2012). Malnutrition and obesity in pediatric oncology patients: Causes, consequences and interventions. Pediatric Blood and Cancer, 59 (7), 1160-1167. doi:10.1002/pbc.24272 Couluris, M., Mayer, J. L., Freyer, D. R., Sandler, E., Xu, P. e Krischer, J. P. (2008). The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (Megace) on weight in children with cancer/ treatment-related cachexia. Journal of Pediatric Hematology Oncology, 30 (11), 791–797. doi:10.1097/MPH.0b013e3181864a5e Cutler, C., Stevenson, K., Kim, H. T., Richardson, P., Ho, V. T., Linden, E., . . . Soiffer, R. (2008). Sirolimus is associated with veno- occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood, 112 (12), 4425–4431. doi:10.1182/ blood-2008-07-169342 Cuvelier, G. D., Baker, T. J., Peddie, E. F., Casey, L. M., Lambert, P. J., Distefano, D. D., . . . Wilson, B. A. (2014). A randomized, double- blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/ or cancer therapy. Pediatric Blood and Cancer, 61 (4), 672-679. doi:10.1002/pbc.24828 Davis, M. E. (2016). Ocular toxicity of tyrosine kinase inhibitors. Oncology Nursing Forum, 43 (2), 235–243. doi:10.1188/16. ONF.235-243 Davis, P. F., Douglas, T. T., Gilbert, C. D., Jansen, C. E., Katz, A., Robinson, C. B., . . . Wilson, B. J. (2014). Side effects of cancer therapy. Em M. Polovich, M. Olsen e K. B. Lefebvre (Eds.), Chemotherapy and biotherapy: Guidelines and recommendations for practice (4 a ed., pp. 184–190). Pittsburgh, PA: Oncology Nursing Society. De, A., Guryev, I., LaRiviere, A., Kato, R., Wee, C. P., Mascarenhas, L., . . . Venkatramani, R. (2014). Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin. Pediatric Blood and Cancer, 61 (9), 1679-1684. doi:10.1002/pbc.25098 de Ville de Goyet, M., Moniotte, S., Robert, A., Dupont, S., Vermylen, C., Veyckemans, F. e Brichard, B. (2013). Iron overload in children undergoing cancer treatments. Pediatric Blood and Cancer, 60 (12), 1982-1987. doi:10.1002/pbc.24705 De Wit, R., Sleijfer, S., Kaye, S. B., Horwich, A. Mead, B., Sleijfer, D. T. e Stoter, G. (2007). Bleomycin and scuba diving: Where is the harm? Lancet Oncology, 8 (11), 954–955. doi:10.1016/S1470-2045(07)70321-2 Defibrotide (Defitelio) for hepatic veno-occlusive disease. (2016, setembro). The Medical Letter, 58 (1503), 120. Extraído de: https:// secure.medicalletter.org/w1503c Del Mastro, L., Ceppi, M., Poggio, F., Bighin, C., Peccatori, F., Demeestere, I., . . . Bruzzi, P. (2014). Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treatment Reviews, 40 (5), 675–683. doi:10.1016/j.ctrv.2013.12.001 DeLoughery, T. G. e Beer, T. M. (2015). Bevacizumab and thrombosis: Some answers but questions remain. Cancer, 121 (7), 975-977. doi:10.1002/cncr.29168 Didem, A., Ayfer, E. e Ferda, O. A. (2014). The effect of chewing gum on oral mucositis in children receiving chemotherapy. Health Science Journal, 8 (3), 373–382. Extraído de: http://www.hsj.gr/medicine/the- effect-of-chewing-gum-on-oral- mucositis-in-children-receiving-chemotherapy.php?aid=2652 Dignan, F. L., Wynn, R. F., Hadzic, N., Kara ni, J., Quaglia, A., Pagliuca, A., . . . Potter, M. N. (2013). BCSH/BSBMT guideline: Diagnosis
C17 Council on Children’s Cancer and Blood Disorders. (2010). Guideline for platelet transfusion thresholds for pediatric hematology/ oncology patients . Extraído de: http://www.c17.ca/index.php?cID=86 Cairo, M. S., Davenport, V., Bessmertny, O., Goldman, S. C., Berg, S. L., Kreissman, S. G., . . . Reaman, G. H. (2005). Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: A clinical, haematological and biological study. British Journal of Haematology, 128 (1), 49–58. doi:10.1111/j.1365-2141.2004.05281.x Cantor, S. B., Elting, L. S., Hudson, D. V. e Rubenstein, E. B. (2003). Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer, 97 (12), 3099– 3106. doi:10.1002/cncr.11447 Cassileth, B. R. e Keefe, F. J. (2010). Integrative and behavioral approaches to the treatment of cancer-related neuropathic pain. The Oncologist, 15 (suppl 2), 19–23. doi:10.1634/theoncologist.2009-S504 Castellino, S. M., Ullrich, N. J., Whelen, M. J. e Lange, B. J. (2014). Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors. Journal of National Cancer Institute, 106 (8). doi:10.1093/jnci/dju186 Cavaletti, G., Alberti, P. e Marmiroli, P. (2015). Chemotherapy-induced peripheral neurotoxicity in cancer survivors: An underdiagnosed clinical entity? American Society of Clinical Oncology Educational Book, 2015, e553–560. doi:10.14694/EdBook AM.2015.35.e553 Cawley, M. M. e Benson, L. M. (2005). Current trends in managing oral mucositis. Clinical Journal of Oncology Nursing, 9 (5), 584–592. doi:10.1188/D5.CJON.584-592 Cheetham, T. e Baylis, P. H. (2002). Diabetes insipidus in children: Pathophysiology, diagnosis and management. Paediatric Drugs, 4 (12), 785–796. Chen, H., Li, J., Cui, T. e Hu, L. (2011). Adjuvant gonadotropin- releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database of Systemic Reviews, 2011 (11), CD008018. doi:10.1002/14651858.CD008018.pub2 Cheuk, D. K. (2012). Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Prophylaxis and treatment controversies. World Journal of Transplantation, 2 (2), 27–34. doi:10.5500/wjt. v2.i2.27 Cheuk, D. K., Chiang, A. K., Chan, G. C. e Ha, S Y. (2017). Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer. Cochrane Database of Systematic Reviews, 3:CD006945. doi:10.1002/14651858.CD006945.pub4 Cheuk, D. K., Chiang, A. K., Ha, S. Y. e Chan, G. C. (2015). Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation. Cochrane Database System Review, 2015 (5), CD009311. doi:10.1002/14651858. CD009311.pub2 Children’s Oncology Group. (2103). Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers (version 4.0, p. 43). Extraído de: http://www.survivorshipguidelines. org/pdf/LTFUGuidelines_40.pdf Children’s Oncology Group. COG supportive care endorsed guidelines . Extraído de: https://childrensoncologygroup.org/downloads/COG_ SC_Guideline_Document.pdf Chumpitazi, B., Lane, M., Czyzewski, D., Weidler, R., Swank, P. e Shulman, R. (2010). Creation and initial evaluation of a stool form scale for children. Journal of Pediatrics, 157 (4), 594–597. doi:10.1016/ jpeds.2010.04.040 Cleveland Clinic. (s.d.). Multigated acquisition scan . Extraído de: http:// my.clevelandclinic.org/heart/services/tests/nuclear/muga.aspx. Coiffier, V., Altman, A., Pui, C. H., Younes, A. e Cairo, M. S. (2008). Guidelines for the management of pediatric and adult tumor lysis
280 Plano de Estudos de Quimioterapia e Bioterapia Pediátrica: Quarta Edição
Powered by FlippingBook